Erschienen: 18.06.2025 Abbildung von Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A | 1. Auflage | 2025 | beck-shop.de

Neu Erschienen: 18.06.2025

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy: Part A

lieferbar ca. 10 Tage als Sonderdruck ohne Rückgaberecht

Rezensionen ansehen

Standardpreis

ca. 147,66 €

Preisangaben inkl. MwSt. Abhängig von der Lieferadresse kann die MwSt. an der Kasse variieren. Weitere Informationen

auch verfügbar als eBook (ePub) für 138 €

Buch. Hardcover

2025

In englischer Sprache

Elsevier Science & Technology. ISBN 978-0-443-34495-4

Format (B x L): 15,2 x 22,9 cm

Gewicht: 450 g

Produktbeschreibung

Advances in DNA and mRNA-Based Strategies for Cancer Immunotherapy, Volume 165 in the Advances in Immunology series, presents current developments and comprehensive reviews in DNA and mRNA vaccines: Significant therapeutic approach against cancer management, Nanoparticles for mRNA-based cancer immunotherapy, Nucleic acid Delivery as a therapeutic approach in cancer immunotherapy, Plasmid DNA and mRNA: Delivery approaches and challenges, Viral & Non-viral Delivery of mRNA against Cancer Cell, Progress in Modifying and Delivering mRNA therapies for Cancer Immunotherapy, and more.

Other chapters cover mRNA-Based Cancer Vaccines: A Novel Approach to Melanoma Treatment, Therapeutic mRNAs for cancer immunotherapy: from structure to delivery, Harnessing the immune system: Insights into cancer vaccines, Lipid Nanoparticle-Mediated mRNA Delivery in Cancer Immunotherapy, Immunotherapy Perspectives in the Era of B-Cell Editing in Cancer Treatment, Personalized Precision: Revolutionizing Cancer Treatment with mRNA-Based Vaccines in Melanoma Therapy, Revolutionizing Cancer Treatment: Exploring Novel Immunotherapeutics, Checkpoints, bispecifics, and Vaccines in Development, and more.